R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2022
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the word "AUDUBON" in black with an image of a cell to the left stylized so that the varying cell structures are shaded differently and the membranes between the structures are frayed to look like a pompom. The cell having a yellow center, followed by a pink layered border and a purple border on the outside.
Titulares
Representantes
Robert Devin Ricci KEAN MILLER LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Providing medical and scientific research information in the field of human pharmaceuticals and human clinical trials; conducting research and clinical trials in the field of human oncology and cancer research; Providing a website featuring educational information in the field of human clinical research; Medical and scientific research, namely, conducting human clinical trials for others; Providing human medical testing services and information in the field of human cancer research and disease classification; technical research and consulting in the field of human pharmaceutical studies; Human pharmaceutical research services; human Pharmaceutical research and development; testing of human pharmaceuticals; Biotechnology research related to humans; Medical research related to humans; Human DNA analysis services for scientific research purposes; Human medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; human medical and scientific research in the field of cancer treatment; Providing research information in the nature of human medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of human cancer treatment for others in the nature of conducting clinical trials for others; Providing clinical trial information in the nature of research data pertaining to cancer; development, validation, and certification of human clinical trials and tests; Design, research, development and testing services in the field of human pharmaceuticals, biobanking, and cancer research; Preclinical research services in the field of human biospecimens collections
Classe 44
collection and preservation of human biologicals, namely, human tissue, blood and bodily fluids; Biobank services, namely, providing access to a collection of human biologicals, namely, human tissue, blood and bodily fluids; Providing human medical information in the nature of medical data pertaining to cancer and its treatment; providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; Human medical testing for diagnostic or treatment purposes; Dispensing of pharmaceuticals to humans
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
REGISTERED-PRINCIPAL REGISTER
04/01/2022
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
25/11/2021
POST PUBLICATION AMENDMENT - ENTERED
24/11/2021
ASSIGNED TO PETITION STAFF
24/11/2021
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/11/2021
EXTENSION OF TIME TO OPPOSE RECEIVED
16/06/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/05/2021
PUBLISHED FOR OPPOSITION
18/05/2021
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/04/2021
APPROVED FOR PUB - PRINCIPAL REGISTER
13/04/2021
EXAMINER'S AMENDMENT ENTERED
13/04/2021
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/04/2021
EXAMINERS AMENDMENT E-MAILED
13/04/2021
EXAMINERS AMENDMENT -WRITTEN
13/04/2021
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2021
NON-FINAL ACTION E-MAILED
09/03/2021
NON-FINAL ACTION WRITTEN
09/03/2021
ASSIGNED TO EXAMINER
04/03/2021
NOTICE OF DESIGN SEARCH CODE E-MAILED
21/11/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/11/2020
NEW APPLICATION ENTERED
09/10/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.